Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis

BACKGROUND: Advanced pulmonary sarcoidosis causes significant morbidity and can lead to death. Large trials demonstrated efficacy of antifibrotics in patients with progressive fibrosing interstitial lung diseases (PF-ILD), including a few with sarcoidosis. To date, little is known about this progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Schimmelpennink, M. C., Meek, D. B., Vorselaars, A. D. M., Langezaal, L. C. M., van Moorsel, C. H. M., van der Vis, J. J., Veltkamp, M., Grutters, J. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233403/
https://www.ncbi.nlm.nih.gov/pubmed/35752806
http://dx.doi.org/10.1186/s12931-022-02094-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233403/
https://www.ncbi.nlm.nih.gov/pubmed/35752806
http://dx.doi.org/10.1186/s12931-022-02094-7

Ejemplares similares